PRESS & NEWS
Press Releases & News
2026-02-15

International Patent Granted for Resveratrol Glycoside

SIRT Lab's proprietary resveratrol glycoside technology has been granted international patents in Japan, the US, and Europe.

SIRT Lab Inc. (headquartered in Tokyo) is pleased to announce that its proprietary resveratrol glycoside technology has been granted international patents in Japan, the United States, and Europe.


This technology dramatically improves light stability and water solubility by binding sugar molecules to trans-resveratrol. It fundamentally resolves the challenges of UV degradation and poor water solubility that conventional resveratrol faced, significantly enhancing its practicality as a cosmetic ingredient.


Going forward, we will accelerate partnerships with domestic and international companies based on this patented technology to advance the development of anti-aging products.

2026-01-20
New Product Line Announced Utilizing Nano Bi-cell Sheet Technology
A new lineup of professional skincare products has been announced, applying our patented Nano Bi-cell Sheet technology.
SIRT Lab Inc. announces a new lineup of professional skincare products applying its patented Nano Bi-cell Sheet technology.

The Nano Bi-cell Sheet is an innovative delivery system that encapsulates active ingredients in nano-scale capsules for efficient delivery to deep skin layers. The new product line deploys this technology across three categories—face cream, serum, and sheet mask—available to OEM/ODM partners.

For sample requests and technical specification inquiries, please use our contact form.
2025-12-10
Exhibiting at COSME TOKYO 2026
We will exhibit at COSME TOKYO 2026, held in January 2026. You can explore our latest glycosylated resveratrol products.
SIRT Lab Inc. will be exhibiting at COSME TOKYO 2026 (14th International Cosmetics Exhibition), held January 15-17 at Tokyo Big Sight.

At our booth, we will showcase the latest product samples utilizing glycosylated resveratrol and Nano Bi-cell Sheet technology, conduct technical demonstrations, and hold individual business meetings.

We welcome OEM/ODM partners and cosmetic manufacturers interested in ingredient sourcing. Pre-scheduled appointments are also available—please feel free to contact us.
2025-11-28
Development Complete: Resveratrol Drink (50ml)
Development of a 50ml drink for internal resveratrol absorption is complete. OEM supply is now available.
SIRT Lab Inc. announces the completion of development for a daily drinkable resveratrol formula (50ml) designed for internal absorption.

This product incorporates our patented glycosylated resveratrol, achieving a formulation with excellent water solubility and stability. In a convenient 50ml size, it enables routine intake of trans-resveratrol.

As a new category product for anti-aging from within, we are now accepting OEM/ODM supply inquiries. Formulation customization is available—please contact us for details.
2025-10-15
Technical Partnership Signed with Major Cosmetics OEM Manufacturer
A technical partnership with a major domestic cosmetics OEM manufacturer has established mass production capabilities for glycosylated resveratrol products.
SIRT Lab Inc. announces the signing of a technical partnership agreement with a major domestic cosmetics OEM manufacturer.

This partnership establishes stable mass production capabilities for glycosylated resveratrol products, enabling rapid market entry for white-label products.

By combining the manufacturing expertise of our partner company with our patented technology, we have established a system capable of providing high-quality products at competitive prices.
2026-02-15
International Patent Granted for Resveratrol Glycoside
SIRT Lab's proprietary resveratrol glycoside technology has been granted international patents in Japan, the US, and Europe.
SIRT Lab Inc. (headquartered in Tokyo) is pleased to announce that its proprietary resveratrol glycoside technology has been granted international patents in Japan, the United States, and Europe.

This technology dramatically improves light stability and water solubility by binding sugar molecules to trans-resveratrol. It fundamentally resolves the challenges of UV degradation and poor water solubility that conventional resveratrol faced, significantly enhancing its practicality as a cosmetic ingredient.

Going forward, we will accelerate partnerships with domestic and international companies based on this patented technology to advance the development of anti-aging products.
2026-01-20

New Product Line Announced Utilizing Nano Bi-cell Sheet Technology

A new lineup of professional skincare products has been announced, applying our patented Nano Bi-cell Sheet technology.
SIRT Lab Inc. announces a new lineup of professional skincare products applying its patented Nano Bi-cell Sheet technology.

The Nano Bi-cell Sheet is an innovative delivery system that encapsulates active ingredients in nano-scale capsules for efficient delivery to deep skin layers. The new product line deploys this technology across three categories—face cream, serum, and sheet mask—available to OEM/ODM partners.

For sample requests and technical specification inquiries, please use our contact form.
2025-11-28
Development Complete: Resveratrol Drink (50ml)
Development of a 50ml drink for internal resveratrol absorption is complete. OEM supply is now available.
SIRT Lab Inc. announces the completion of development for a daily drinkable resveratrol formula (50ml) designed for internal absorption.

This product incorporates our patented glycosylated resveratrol, achieving a formulation with excellent water solubility and stability. In a convenient 50ml size, it enables routine intake of trans-resveratrol.

As a new category product for anti-aging from within, we are now accepting OEM/ODM supply inquiries. Formulation customization is available—please contact us for details.
2025-10-15
Technical Partnership Signed with Major Cosmetics OEM Manufacturer
A technical partnership with a major domestic cosmetics OEM manufacturer has established mass production capabilities for glycosylated resveratrol products.
SIRT Lab Inc. announces the signing of a technical partnership agreement with a major domestic cosmetics OEM manufacturer.

This partnership establishes stable mass production capabilities for glycosylated resveratrol products, enabling rapid market entry for white-label products.

By combining the manufacturing expertise of our partner company with our patented technology, we have established a system capable of providing high-quality products at competitive prices.
2025-12-10
Exhibiting at COSME TOKYO 2026
We will exhibit at COSME TOKYO 2026, held in January 2026. You can explore our latest glycosylated resveratrol products.
SIRT Lab Inc. will be exhibiting at COSME TOKYO 2026 (14th International Cosmetics Exhibition), held January 15-17 at Tokyo Big Sight.

At our booth, we will showcase the latest product samples utilizing glycosylated resveratrol and Nano Bi-cell Sheet technology, conduct technical demonstrations, and hold individual business meetings.

We welcome OEM/ODM partners and cosmetic manufacturers interested in ingredient sourcing. Pre-scheduled appointments are also available—please feel free to contact us.

Safety & Compliance

安全性と規制対応を最優先に、信頼される技術提供を実現します

安全性への考え方
天然由来酵素
レスベラトロールの配糖化プロセスには、化学合成ではなく天然酵素を使用。体に優しい製造方法を採用しています。
化粧品原料としての位置づけ
化粧品原料基準に適合した形で提供。安全性データの蓄積も継続的に実施しています。
品質管理体制
厳格な品質管理基準のもと、一定の品質を保証。トレーサビリティも完備しています。
規制対応
化粧品区分での提供
現時点では化粧品原料としての提供に特化。薬機法に準拠した適切な供給体制を構築しています。
表現ガイドライン
パートナー企業様向けに、薬機法に適合した表現ガイドラインを提供。コンプライアンス支援を実施します。
海外規制対応
主要市場における化粧品規制への対応を進行中。グローバル展開をサポートします。
将来展望
エビデンス取得
第三者機関との連携により、科学的エビデンスの蓄積を継続。技術の信頼性を強化します。
医薬部外品への拡張
必要なデータ取得と承認プロセスを経て、医薬部外品領域への展開も視野に入れています。
医療応用の可能性
長期的には医療機器や医薬品への応用も検討。研究開発を継続しています。
コンプライアンス体制

        当社は、化粧品・健康美容業界における規制を遵守し、パートナー企業様が安心してビジネスを展開できる環境を提供します。

提供時のサポート
  • 安全性データシートの提供
  • 成分表示に関するガイダンス
  • 薬機法対応の表現サポート
  • 製造・品質管理に関する技術情報
継続的な取り組み
  • 最新の規制動向のモニタリング
  • 安全性試験の継続的実施
  • 品質管理プロセスの改善
  • 業界団体との連携・情報共有

重要な注記:当社は化粧品原料の提供を行う企業です。個人のお客様への直接販売や、個人情報の収集、医療行為に関するサービスは提供しておりません。すべての取引は事業者間(B2B)で行われます。